Search
for
Sort by
Research 811–840 of 1000+
- Polymeric Nanohydrogel in Topical Drug Delivery System
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Type 2 Diabetic Mellitus Inhibits Skin Renewal through Inhibiting WNT-Dependent Lgr5+ Hair Follicle Stem Cell Activation in C57BL/6 Mice
- New frontiers in CRISPR/Cas9 delivery systems delivery for gene editing
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial
- Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
- Disease Prevention and Alleviation by Human Myoblast Transplantation
- Treatment of androgenetic alopecia with 5-aminolevulinic acid photodynamic therapy: A randomized, placebo-controlled, split-scalp study of efficacy and safety
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- The Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Adjunct Treatment with Platelet-rich Plasma for the Treatment of Inflammatory Alopecia in an Adult Filipino Female with Systemic Lupus Erythematosus
- Photobiomodulation or low‐level laser therapy
- Liposome-Based Carriers for CRISPR Genome Editing
- Characterization of the Human Hair Keratin–Associated Protein 2 (KRTAP2) Gene Family
- Agent specific effects of anticoagulant induced alopecia
- Integrated edge information and pathway topology for drug-disease associations
- Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
- Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Tolerability, acceptability, and reproducibility of topical STAR particles in human subjects
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- Treatment of Full-Thickness Skin Wounds with Blood-Derived CD34+ Precursor Cells Enhances Healing with Hair Follicle Regeneration
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs